<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">V.F.Snegirev Archives of Obstetrics and Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">V.F.Snegirev Archives of Obstetrics and Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Архив акушерства и гинекологии им. В.Ф. Снегирева</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-8726</issn><issn publication-format="electronic">2687-1386</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">697282</article-id><article-id pub-id-type="doi">10.17816/aog697282</article-id><article-id pub-id-type="edn">EPVLWC</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original study articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="zh"><subject>Original study articles</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Proliferative activity and expression of estrogen receptors in endometrial mesenchymal stromal cells in patients with repeated implantation failure</article-title><trans-title-group xml:lang="ru"><trans-title>Пролиферативная активность и экспрессия эстрогеновых рецепторов в мезенхимальных стромальных клетках эндометрия у пациенток с повторными неудачами имплантации</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>反复种植失败患者子宫内膜间充质基质细胞的增殖活性及雌激素受体表达</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-3219-2412</contrib-id><name-alternatives><name xml:lang="en"><surname>Ivashchenko</surname><given-names>Dariya V.</given-names></name><name xml:lang="ru"><surname>Иващенко</surname><given-names>Дарья Владимировна</given-names></name><name xml:lang="zh"><surname>Ivashchenko</surname><given-names>Dariya V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>nanomy_1@icloud.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-2367-3238</contrib-id><name-alternatives><name xml:lang="en"><surname>Mangusheva</surname><given-names>Veronika A.</given-names></name><name xml:lang="ru"><surname>Мангушева</surname><given-names>Вероника Александровна</given-names></name><name xml:lang="zh"><surname>Mangusheva</surname><given-names>Veronika A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>veronikamanguseva@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9885-9056</contrib-id><contrib-id contrib-id-type="spin">9473-2564</contrib-id><name-alternatives><name xml:lang="en"><surname>Sysoeva</surname><given-names>Veronika Yu.</given-names></name><name xml:lang="ru"><surname>Сысоева</surname><given-names>Вероника Юрьевна</given-names></name><name xml:lang="zh"><surname>Sysoeva</surname><given-names>Veronika Yu.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biology), Associate Professor</p></bio><bio xml:lang="ru"><p>канд. биол. наук, доцент</p></bio><bio xml:lang="zh"><p>Cand. Sci. (Biology), Associate Professor</p></bio><email>veroniks@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1797-1634</contrib-id><name-alternatives><name xml:lang="en"><surname>Eremichev</surname><given-names>Roman Yu.</given-names></name><name xml:lang="ru"><surname>Еремичев</surname><given-names>Роман Юрьевич</given-names></name><name xml:lang="zh"><surname>Eremichev</surname><given-names>Roman Yu.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Medicine)</p></bio><email>eremichevry@my.msu.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-9311-4777</contrib-id><name-alternatives><name xml:lang="en"><surname>Nikitina</surname><given-names>Tatyana V.</given-names></name><name xml:lang="ru"><surname>Никитина</surname><given-names>Татьяна Владиславна</given-names></name><name xml:lang="zh"><surname>Nikitina</surname><given-names>Tatyana V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>nikitinamide@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2681-4777</contrib-id><contrib-id contrib-id-type="spin">3138-4565</contrib-id><name-alternatives><name xml:lang="en"><surname>Shcherbakova</surname><given-names>Liya N.</given-names></name><name xml:lang="ru"><surname>Щербакова</surname><given-names>Лия Ниязовна</given-names></name><name xml:lang="zh"><surname>Shcherbakova</surname><given-names>Liya N.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Associate Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, доцент</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Medicine), Associate Professor</p></bio><email>liya.fbm@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8869-5190</contrib-id><contrib-id contrib-id-type="spin">7259-9180</contrib-id><name-alternatives><name xml:lang="en"><surname>Makarevich</surname><given-names>Pavel I.</given-names></name><name xml:lang="ru"><surname>Макаревич</surname><given-names>Павел Игоревич</given-names></name><name xml:lang="zh"><surname>Makarevich</surname><given-names>Pavel I.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>д-р мед. наук</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Medicine)</p></bio><email>pavel.makarevich@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6103-3100</contrib-id><name-alternatives><name xml:lang="en"><surname>Mladova</surname><given-names>Elena S.</given-names></name><name xml:lang="ru"><surname>Младова</surname><given-names>Елена Сергеевна</given-names></name><name xml:lang="zh"><surname>Mladova</surname><given-names>Elena S.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>e.mladova@remediclinic.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3497-9619</contrib-id><contrib-id contrib-id-type="spin">6300-6946</contrib-id><name-alternatives><name xml:lang="en"><surname>Kalinina</surname><given-names>Natalia I.</given-names></name><name xml:lang="ru"><surname>Калинина</surname><given-names>Наталья Игоревна</given-names></name><name xml:lang="zh"><surname>Kalinina</surname><given-names>Natalia I.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biology), Associate Professor</p></bio><bio xml:lang="ru"><p>канд. биол. наук, доцент</p></bio><bio xml:lang="zh"><p>Cand. Sci. (Biology), Associate Professor</p></bio><email>n_i_kalinina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1397-6208</contrib-id><contrib-id contrib-id-type="spin">2105-6871</contrib-id><name-alternatives><name xml:lang="en"><surname>Panina</surname><given-names>Olga B.</given-names></name><name xml:lang="ru"><surname>Панина</surname><given-names>Ольга Борисовна</given-names></name><name xml:lang="zh"><surname>Panina</surname><given-names>Olga B.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><email>olgapanina@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">Московский государственный университет им. М.В. Ломоносова</institution></aff><aff><institution xml:lang="zh">Lomonosov Moscow State University</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Institute of Reproductive Medicine REMEDI</institution></aff><aff><institution xml:lang="ru">Институт репродуктивной медицины REMEDI</institution></aff><aff><institution xml:lang="zh">Institute of Reproductive Medicine REMEDI</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2026-02-28" publication-format="electronic"><day>28</day><month>02</month><year>2026</year></pub-date><pub-date date-type="pub" iso-8601-date="2026-04-21" publication-format="electronic"><day>21</day><month>04</month><year>2026</year></pub-date><volume>13</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><issue-title xml:lang="zh"/><fpage>48</fpage><lpage>58</lpage><history><date date-type="received" iso-8601-date="2025-12-02"><day>02</day><month>12</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-12-09"><day>09</day><month>12</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2026, Eco-Vector</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><copyright-holder xml:lang="zh">Eco-Vector</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2028-04-21"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref></license></permissions><self-uri xlink:href="https://archivog.com/2313-8726/article/view/697282">https://archivog.com/2313-8726/article/view/697282</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND</bold><bold>:</bold> Endometrial receptivity disorders are the primary focus in patients with repeated implantation failure. However, the cellular and receptor characteristics of endometrial mesenchymal stromal cells in this population remain poorly understood, especially in terms of proliferative activity and estrogen receptor expression. This work examined the proliferative activity and expression of estrogen receptors in endometrial mesenchymal stromal cells in these patients to identify a new pathogenetic link of infertility and potential therapeutic targets.</p> <p><bold>AIM</bold><bold>:</bold> The work aimed to assess the functional characteristics of endometrial mesenchymal stromal cells, including their proliferative activity and estrogen receptor expression, in patients with repeated failure of euploid embryo implantation.</p> <p><bold>METHODS</bold><bold>:</bold> This pilot study included five patients aged 25–40 years. The main group included four patients with repeated implantation failure. An endometrial sample from a surrogate mother with a history of six term births served as a positive control. Mesenchymal stromal cells were isolated from endometrial aspiration biopsy samples collected during the first phase of the menstrual cycle. <italic>ESR1</italic> expression was assessed by real-time polymerase chain reaction, and estrogen receptor alpha (ERα) levels were measured by fluorescent immunocytochemistry. The proliferative activity of mesenchymal stromal cells was assessed in the IncuCyte live-cell analysis system in a control medium and with 0.1 nM 17β-estradiol.</p> <p><bold>RESULTS</bold><bold>:</bold> <italic>ESR1</italic> mRNA levels in cultured endometrial mesenchymal stromal cells were approximately 10 times higher than in adipose tissue mesenchymal stromal cells. Immunocytochemistry revealed specific expression of nuclear ERα in all samples. Patients with unexplained infertility had fewer receptors than the control group, with the lowest ERα expression reported in patients with tubal-peritoneal infertility. Endometrial mesenchymal stromal cells from patients with repeated implantation failure had a significantly lower proliferation rate than mesenchymal stromal cells from a surrogate mother. Patients with unexplained infertility had the lowest proliferative capacity of endometrial mesenchymal stromal cells. Adding 17β-estradiol significantly increased endometrial mesenchymal stromal cell proliferation in both the surrogate mother and patients with unexplained infertility. In patients with tubal-peritoneal infertility, 0.1 nM estradiol did not improve endometrial mesenchymal stromal cells proliferation.</p> <p><bold>CONCLUSION</bold><bold>:</bold> This work is the first to demonstrate decreased proliferative activity and expression of estrogen receptors (ERα) in endometrial mesenchymal stromal cells in patients with repeated implantation failure. The findings indicate that mesenchymal stromal cells from patients with unexplained infertility remain sensitive to estrogen despite the reduced number of receptors. These data add to a better understanding of the functional characteristics of endometrial mesenchymal stromal cells in repeated implantation failure.</p></abstract><trans-abstract xml:lang="ru"><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p><bold>Обоснование. </bold>У пациенток с повторными неудачами имплантации основной акцент делается на нарушение рецептивности эндометрия, однако клеточные и рецепторные особенности эндометриальных мезенхимальных стромальных клеток в этой группе остаются практически не изученными, особенно на уровне пролиферативной активности и экспрессии эстрогеновых рецепторов. Настоящее исследование призвано охарактеризовать пролиферативную активность и экспрессию эстрогеновых рецепторов в мезенхимальных стромальных клетках эндометрия у пациенток данной группы для выявления нового звена патогенеза бесплодия и потенциальных терапевтических мишеней.</p> <p><bold>Цель исследования. </bold>Изучить функциональные свойства мезенхимальных стромальных клеток эндометрия, в частности их пролиферативную активность и экспрессию эстрогеновых рецепторов, у пациенток с повторными неудачами имплантации эуплоидных эмбрионов.</p> <p><bold>Методы. </bold>В пилотное исследование включены 5 пациенток в возрасте 25–40 лет. Основную группу составили 4 пациентки с повторными неудачами имплантации. В качестве положительного контроля использован образец эндометрия суррогатной матери с шестью своевременными родами в анамнезе. Мезенхимальные стромальные клетки выделяли из биоптатов эндометрия, полученных путём аспирационной биопсии в первой фазе менструального цикла. Экспрессию гена <italic>ESR1</italic> определяли методом ПЦР в реальном времени, белок эстрогенового рецептора α (ERα) — иммуноцитохимически с флуоресцентными антителами. Пролиферативную активность мезенхимальных стромальных клеток оценивали в системе анализа живых клеток IncuCyte в контрольной среде и при добавлении 17β-эстрадиола 0,1 нM.</p> <p><bold>Результаты. </bold>Содержание мРНК эстрогенового рецептора <italic>ESR1</italic> в культивируемых мезенхимальных стромальных клетках эндометрия оказалось приблизительно в 10 раз выше по сравнению с мезенхимальными стромальными клетками жировой ткани. Иммуноцитохимическое исследование выявило специфическую экспрессию ядерных ERα во всех образцах, при этом у пациенток с бесплодием неясного генеза количество рецепторов было снижено относительно контроля, а наименьший уровень экспрессии ERα обнаружен при трубно-перитонеальном бесплодии. Мезенхимальные стромальные клетки эндометрия пациенток с повторными неудачами имплантации продемонстрировали достоверно более низкую скорость пролиферации по сравнению с мезенхимальными стромальными клетками суррогатной матери. Наименьшая пролиферативная способность мезенхимальных стромальных клеток эндометрия обнаружена у пациенток с бесплодием неясного генеза. Добавление 17β-эстрадиола вызвало статистически значимое увеличение скорости пролиферации мезенхимальных стромальных клеток эндометрия как у суррогатной матери, так и у пациенток с бесплодием неясного генеза. У пациенток с трубно-перитонеальным бесплодием эстрадиол в концентрации 0,1 нМ не стимулировал пролиферацию мезенхимальных стромальных клеток эндометрия.</p> <p><bold>Заключение.</bold> Впервые продемонстрировано снижение пролиферативной активности и экспрессии эстрогеновых рецепторов (ERα) в мезенхимальных стромальных клетках эндометрия у пациенток с повторными неудачами имплантации. Полученные данные свидетельствуют о том, что мезенхимальные стромальные клетки пациенток с бесплодием неясного генеза сохраняют чувствительность к эстрогену, несмотря на снижение количества рецепторов. Результаты исследования расширяют фундаментальные представления о функциональных особенностях эндометриальных мезенхимальных стромальных клеток при повторных неудачах имплантации.</p>   <p> </p>        </trans-abstract><trans-abstract xml:lang="zh"><p><bold>论证。</bold> 在反复种植失败的患者中，主要关注点在于子宫内膜容受性的受损，然而该群体中子宫内膜间充质基质细胞的细胞和受体特征，特别是在增殖活性和雌激素受体表达水平上，仍基本未被研究。本研究旨在表征该组患者子宫内膜间充质基质细胞的增殖活性和雌激素受体表达，以揭示不孕症发病机制的新环节和潜在的治疗靶点。</p> <p><bold>目的。</bold> 研究反复整倍体胚胎种植失败患者子宫内膜间充质基质细胞的功能特性，特别是其增殖活性和雌激素受体表达。</p> <p><bold>方法。</bold> 初步研究纳入了5名25–40岁的女性患者。主要组由4名反复种植失败的患者组成。阳性对照采用一名有6次足月产史的代孕母亲的子宫内膜样本。间充质基质细胞分离自月经周期第一阶段通过抽吸活检获取的子宫内膜活检组织。ESR1基因表达采用实时定量PCR法检测，雌激素受体α (ERα) 蛋白采用荧光抗体免疫细胞化学法检测。在对照培养基及添加0.1 nM 17β-雌二醇的条件下，利用IncuCyte活细胞分析系统评估间充质基质细胞的增殖活性。</p> <p><bold>结果。</bold> 培养的子宫内膜间充质基质细胞中雌激素受体 ESR1 mRNA 的含量约为脂肪组织间充质基质细胞的 10 倍。免疫细胞化学研究显示，所有样本中均存在核 ERα 的特异性表达，其中不明原因不孕症患者的受体数量较对照组有所减少，而在输卵管腹膜性不孕症患者中发现 ERα 的表达水平最低。反复着床失败患者的子宫内膜间充质基质细胞增殖速率显著低于代孕母亲的间充质基质细胞。在不明原因不孕症患者中发现子宫内膜间充质基质细胞的增殖能力最低。添加 17β-雌二醇使代孕母亲和不明原因不孕症患者的子宫内膜间充质基质细胞增殖速率均出现统计学显著增加。在输卵管腹膜性不孕症患者中，浓度为 0.1 nM 的雌二醇未能刺激子宫内膜间充质基质细胞的增殖。</p> <p><bold>结论。</bold> 首次证实了反复种植失败患者子宫内膜间充质基质细胞中增殖活性和雌激素受体 (ERα) 表达的降低。所得数据表明，尽管受体数量减少，不明原因不孕症患者的间充质基质细胞仍保持对雌激素的敏感性。研究结果扩展了关于反复着床失败中子宫内膜间充质基质细胞功能特征的基础认识。</p></trans-abstract><kwd-group xml:lang="en"><kwd>endometrial mesenchymal stromal cells</kwd><kwd>unexplained infertility</kwd><kwd>repeated implantation failure</kwd><kwd>estrogen receptor ERα</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>мезенхимальные стволовые клетки эндометрия</kwd><kwd>бесплодие неясного генеза</kwd><kwd>повторные неудачи имплантации</kwd><kwd>эстрогеновый рецептор ERα</kwd></kwd-group><kwd-group xml:lang="zh"><kwd>子宫内膜间充质干细胞，不明原因不孕，反复种植失败，雌激素受体 ERα</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Российский научный фонд</institution></institution-wrap><institution-wrap><institution xml:lang="en">Russian Science Foundation</institution></institution-wrap><institution-wrap><institution xml:lang="zh">Russian Science Foundation</institution></institution-wrap></funding-source><award-id>25-75-30005</award-id></award-group><funding-statement xml:lang="en">The study was conducted as part of a state-funded assignment of Lomonosov Moscow State University (cell isolation and primary culture) and supported by the Russian Science Foundation grant No. 25-75-30005 (proliferation and expression assessment by polymerase chain reaction)</funding-statement><funding-statement xml:lang="ru">Исследование выполнено в рамках Государственного задания МГУ им. М.В. Ломоносова (выделение клеток и первичная культура) при поддержке гранта Российского научного фонда № 25-75-30005 (оценка пролиферации и экспрессии рецепторов методом ПЦР)</funding-statement><funding-statement xml:lang="zh">The study was conducted as part of a state-funded assignment of Lomonosov Moscow State University (cell isolation and primary culture) and supported by the Russian Science Foundation grant No. 25-75-30005 (proliferation and expression assessment by polymerase chain reaction)</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Zhang S, Chan RWS, Ng EHY, Yeung WSB. The role of Notch signaling in endometrial mesenchymal stromal/stem-like cells maintenance. Commun Biol. 2022;5(1):1064. doi: 10.1038/s42003-022-04044-x. EDN: GQCCRG</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Eremichev R, Kulebyakina M, Alexandrushkina N, et al. Scar-Free healing of endometrium: tissue-specific program of stromal cells and its induction by soluble factors produced after damage. Front Cell Dev Biol. 2021;9:616893. doi: 10.3389/fcell.2021.616893 EDN: PRDYCO</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Patterson AL, George JW, Chatterjee A, et al. Putative human myometrial and fibroid stem-like cells have mesenchymal stem cell and endometrial stromal cell properties. Hum Reprod. 2020;35(1):44–57. doi: 10.1093/humrep/dez247 EDN: NZFWAI</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Li T, He H, Liu R, et al. Isolation and identification of epithelial and stromal stem cells from eutopic endometrium of women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2014;178:89–94. doi: 10.1016/j.ejogrb.2014.04.001</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Min J, Lu N, Huang S, et al. Phenotype and biological characteristics of endometrial mesenchymal stem/stromal cells: A comparison between intrauterine adhesion patients and healthy women. Am J Reprod Immunol. 2021;85(6):e13379. doi: 10.1111/aji.13379 EDN: DEHQNF</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Anikina TA, Sysoeva VYu, Rubina KA, Radzinsky VE. Expression of mesenchymal cellular markers in the endometrium in health and in proliferative uterine diseases. Obstetrics and Gynecology. 2016;(9):79–86. doi: 10.18565/aig.2016.9.79-86 EDN: WWWPWV</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Hubbard SA, Friel AM, Kumar B, et al. Evidence for cancer stem cells in human endometrial carcinoma. Cancer Res. 2009;69(21):8241–8248. doi: 10.1158/0008-5472.CAN-08-4808 EDN: XXDGUQ</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Leyendecker G, Herbertz M, Kunz G, Mall G. Endometriosis results from the dislocation of basal endometrium. Hum Reprod. 2002;17(10):2725–2736. doi: 10.1093/humrep/17.10.2725 EDN: IPHWFH</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Spitzer TL, Rojas A, Zelenko Z, et al. Perivascular human endometrial mesenchymal stem cells express pathways relevant to self-renewal, lineage specification, and functional phenotype. Biol Reprod. 2012;86(2):58. doi: 10.1095/biolreprod.111.095885</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Gargett CE, Chan RW, Schwab KE. Hormone and growth factor signaling in endometrial renewal: role of stem/progenitor cells. Mol Cell Endocrinol. 2008;288(1-2):22–29. doi: 10.1016/j.mce.2008.02.026 EDN: XVECAD</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Zlatska AV, Gordiienko IM, Zubov DO, et al. Expression of estrogen and progesterone receptors by human endometrial multipotent mesenchymal stromal/stem cells in vitro under hypoxia conditions. Biotechnologia Acta. 2019;12(1):81–85. doi: 10.15407/biotech12.01.081 EDN: NPAEJR</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Szukiewicz D, Stangret A, Ruiz-Ruiz C, et al. Estrogen- and progesterone (P4)-mediated epigenetic modifications of endometrial stromal cells (EnSCs) and/or mesenchymal stem/stromal cells (MSCs) in the etiopathogenesis of endometriosis. Stem Cell Rev Rep. 2021;17(4):1174–1193. doi: 10.1007/s12015-020-10115-5 EDN: YXZDQG</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Fuentes N, Silveyra P. Estrogen receptor signaling mechanisms. Adv Protein Chem Struct Biol. 2019;116:135–170. doi: 10.1016/bs.apcsb.2019.01.001</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Paech K, Webb P, Kuiper GG, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 1997;277(5331):1508–1510. doi: 10.1126/science.277.5331.1508. EDN: CNSOUR</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Jain M, Mladova E, Shichanina A, et al. Microbiological and cytokine profiling of menstrual blood for the assessment of endometrial receptivity: a pilot study. Biomedicines. 2023;11(5):1284. doi: 10.3390/biomedicines11051284EDN: HBBGTY</mixed-citation></ref></ref-list></back></article>
